Prof. Sevgi GÜNGÖR

Metrics

Publication

188

Publication (WoS)

Publication (Scopus)

Citation (WoS)

734

H-Index (WoS)

Citation (Scopus)

1127

H-Index (Scopus)

Citation (Scholar)

406

H-Index (Scholar)

Citation (TrDizin)

H-Index (TrDizin)

Citation (Sum Other)

Project

Intellectual Property

Thesis Advisory

Open Access

UN Sustainable Development Goals

Education

1995 - 2001

Doctorate

Istanbul University, Eczacılık Fakültesi/Sağlık Bilimleri Enstitüsü/Farmasötik Teknoloji Anabilim Dalı, Eczacılık Teknolojisi/Farmasötik Teknoloji Anabilim Dalı, Turkey

1991 - 1993

Postgraduate

Istanbul University, Eczacılık Fakültesi/Sağlık Bilimleri Enstitüsü/Farmasötik Teknoloji Anabilim Dalı, Eczacılık Teknolojisi/Farmasötik Teknoloji, Turkey

1987 - 1991

Undergraduate

Istanbul University, Faculty of Pharmacy , Turkey

Foreign Languages

C1 Advanced

English

Research Areas

Health Sciences

Pharmacology and Therapeutics

Pharmaceutics Technology

Pharmaceutical Technology

Academic Positions

2017 - Present

Professor

Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology

2011 - 2017

Associate Professor

Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology

2004 - 2011

Assistant Professor

Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology

2001 - 2004

Research Assistant PhD

Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology

1992 - 2001

Research Assistant

Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology

Managerial Experience

2017 - Present

Head of Department

Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology

Courses

Doctorate

İn vivo- İn vitro Korelasyon

Deriden emilim ve mekanizmasIndaki matemetiksel modeller

İn vivo- in vitro korelasyon

In vitro- In vivo Korelasyon

İn vivo- in vitro korelasyon

Postgraduate

İlaçların biyolojik membranlardan geçişinin artırılmasında fiziksel ve kimyasal yöntemler

Biyoyararlanım ve biyoeşdeğerlik

İn vitro çözünme testleri ve verilerin değerlendirilmesi

Biyoyararlanım ve biyoeşdeğerlik

İlaçların biyolojik membranlardan geçişinin artırılmasında fiziksel ve kimyasal yöntemler

İn vitro çözünme testleri ve verilerin değerlendirilmesi

Biyoyaralanım Biyoeşdeğerlik

İn vitro çözünme testleri ve verilerin değerlendirilmesi

Biyoyararlanım ve Biyoeşdeğerlik

İlaçların biyolojik membranlardan geçişinin artırılmasında fiziksel ve kimyasal yöntemler

Undergraduate

Biopharmaceutics and Pharmacokinetics

Biyofarmasötikler ve Farmakokinetik

Medikal Biyomedikal Cihaz ve Ürünler

Farmasötik Teknoloji II

Biyofarmasötik Farmakokinetik

Farmasötik Teknoloji II Dersi

Farmasötik Teknoloji I

Nanofarmasötikler

Farmasötik Teknoloji I Dersi

Biyofarmasötik Farmakokinetik

Farmasötik Teknoloji II

Medikal Biyomedikal Cihaz ve Ürünler

Farmasötik Teknoloji I

Supervised Theses

in Progress

Doctorate

In Vitro Permeasyon Çalışmaları İçin Deriyi Taklit Eden Yapay Membran Modellerinin Tasarlanması

Güngör S. (Advisor)

H.ŞAHİN(Student)

in Progress

Doctorate

Kortikosteroitlerin Topikal Biyoyararlanımının İn Vitro ve İn Vivo Yaklaşımlarla Değerlendirilmesi

GÜNGÖR S.

G.Sarıbey(Student)

in Progress

Doctorate

Oral Yol İle Uygulanan İlaçların In Vivo Performasının Tahmin Edilmesine Yönelik In Vitro ve In Siliko Yöntemlerin Geliştirilmesi

Güngör S., Fotakı N.(Advisor)

Ç.ÇAVUŞOĞLU(Student)

in Progress

Doctorate

Nanokristal Teknolojisi İle Dermatolojik İlaçların Topikal Biyoyararlanımının Arttırılması

Güngör S. (Advisor)

E.KALAMİ(Student)

in Progress

Postgraduate

Posakonazolün Farklı Üretim Teknikleri ile Süspansiyon Formülasyonlarının Geliştirilmesi ve In Vitro Performanslarının Değerlendirilmesi

Güngör S. (Advisor)

M.ÖZDEN(Student)

2021

Postgraduate

Biyofarmasötik Sınıflandırma Sistemi Sınıf II Molekülün Çözünürlüğünün Arttırılması Yaklaşımı ile Lipit Yapılı Nanotaşıyıcıların Geliştirilmesi

Güngör S. (Advisor)

G.HUSUZADE(Student)

2019

Postgraduate

Kolekalsiferolün Yeni Katı Dozaj Formunun QbD Yaklaşımı ile Geliştirilmesi.

Güngör S. (Advisor)

N.YILMAZ(Student)

2018

Doctorate

Dendritik Nanotaşıyıcı Sistemlerin Derideki Durumu ve İlaçların Dermal Hedeflendirilmesi Açısından Değerlendirilmesi

Güngör S., Guy R. H.(Advisor)

B.Betül(Student)

2018

Postgraduate

Topikal Preparatların İn vitro Deriden Geçişlerinin Değerlendirilmesinde Kullanılan Membranların Karşılaştırılması

GÜNGÖR S.

N.Özge(Student)

2017

Doctorate

Topikal Psoriazis Tedavisi için Nano Boyutlu İlaç Taşıyıcı Sistemlerin Geliştirilmesi ve İn vitro Modeller ile Değerlendirilmesi

GÜNGÖR S.

M.Rezigue(Student)

2017

Doctorate

Atopik Dermatit Tedavisine Yönelik Topikal Nano İlaç Taşıyıcı Sistemlerin Optimizasyonu, İn vitro/İn vivo Değerlendirilmesi

GÜNGÖR S.

S.Güngördük(Student)

2013

Postgraduate

Etodolak’ın Topikal Mikroemülsiyon Formülasyonlarının Geliştirilmesi ve In vitro Karakterizasyonu Çalışmaları

GÜNGÖR S.

G.Sarıbey(Student)

2011

Postgraduate

Antiemetik İlaçların Transdermal İyontoforetik Geçişinin İncelenmesi

GÜNGÖR S.

D.Özdin(Student)

2010

Postgraduate

Alzheimer Tedavisine Yönelik Bazı İlaçların Transdermal Formülasyon Patentlerinin İncelenmesi Ve Ar-Ge Açısından Değerlendirilmesi

GÜNGÖR S.

M.Türkay(Student)

Articles

2025

1. Comprehensive Analytical Studies on the Solubility and Dissolution Rate Enhancement of Tadalafil with Type IV Lipid Formulations

Husuzade G., Demiralp B., Nazlı H., Boran T., Güngör S.

Pharmaceutics , vol.17, no.11, pp.1-18, 2025 (Peer-Reviewed Journal)

2025

2. In Vitro Antimicrobial Activity and In Vivo Effectiveness of the Cosmetic Products Developed for Oily Skin

ERDAL M. S., Aydilek N., GÜNGÖR S., DÖŞLER S., OYARDI Ö., Alici M., et al.

ISTANBUL JOURNAL OF PHARMACY , vol.55, no.2, pp.160-172, 2025 (ESCI, TRDizin)

2025

3. Evaluation of Physicochemical, Microstructure Parameters (Q3) and Performance Attributes of Commercial Ketoprofen Gels

Iskin S., Kahraman E., GÜNGÖR S.

AAPS PHARMSCITECH , no.2, 2025 (SCI-Expanded)

2024

4. Synthetic membrane selection for in vitro release testing (IVRT): A case study of topical mometasone furoate semi-solid dosage forms

Sarıbey G., Kahraman E., GÜNGÖR S.

European Journal of Pharmaceutical Sciences , vol.203, 2024 (SCI-Expanded)

2024

5. Formulation development and evaluation of fluvastatin loaded transethosomes: Characterization, stability, in vitro dermal penetration, cytotoxicity and antipsoriatic activity studies

Yurtsever A., Ekmekcioglu A., MÜFTÜOĞLU M., GÜNGÖR S., ERDAL M. S.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.91, 2024 (SCI-Expanded)

2023

6. The Design and Optimization of Ceramide NP-Loaded Liposomes to Restore the Skin Barrier

ŞAHİN BEKTAY H., SAĞIROĞLU A. A., Bozali K., Guler E. M., GÜNGÖR S.

PHARMACEUTICS , vol.15, no.12, 2023 (SCI-Expanded)

2023

7. Development and Validation of a Simple and Selective Chromatographic Method for Quantification of Ceramide-NP in Skin-Simulating Liposome Formulations

ŞAHİN BEKTAY H., KAHRAMAN ŞİRİN E., Guengoer S.

JOURNAL OF COSMETIC SCIENCE , vol.74, no.5, pp.275-288, 2023 (SCI-Expanded)

2023

8. Systematic Screening Study for the Selection of Proper Stabilizers to Produce Physically Stable Canagliflozin Nanosuspension by Wet Milling Method

Pirincci Tok Y., MESUT B., GÜNGÖR S., Sarıkaya A. O., Aldeniz E. E., Dude U., et al.

Bioengineering , vol.10, no.8, 2023 (SCI-Expanded)

2023

9. Biopolymer-Based Nanogel Approach in Drug Delivery: Basic Concept and Current Developments

Altuntas E., özkan b., Güngör S., OZSOY Y.

PHARMACEUTICS , vol.15, no.6, pp.1644, 2023 (SCI-Expanded)

2023

10. Nanofibers in Ocular Drug Targeting and Tissue Engineering: Their Importance, Advantages, Advances, and Future Perspectives

Uzel E., Durgun M. E., Esentürk-Güzel İ., GÜNGÖR S., Özsoy Y.

Pharmaceutics , vol.15, no.4, 2023 (SCI-Expanded)

2023

11. Evaluation of Critical Quality Attributes of Dapsone Gel

Kalami E., Kahraman E., Dedeoğlu E., Gürbüz K., Özsoy Y., GÜNGÖR S.

Dissolution Technologies , vol.30, no.1, pp.30-35, 2023 (SCI-Expanded)

2023

12. The effect of biocompatible carriers with vitamin D and platelet-rich plasma (PRP) on bone defects

Turgut C. T., Civelek D. O., KOTİL T., GÜNGÖR S., Ozsoy Y., Dirican A., et al.

HIPPOKRATIA , vol.27, no.2, pp.48-56, 2023 (SCI-Expanded)

2023

13. Excipients for Orally Disintegrating Tablets: Compaction Data Analysis and Study of Tableting Properties of Lubricated Co-processed Excipients

Onayo M. M., Özalp Y., Jiwa N., MESUT B., GÜNGÖR S.

Latin American Journal of Pharmacy , vol.42, no.8, pp.1655-1665, 2023 (SCI-Expanded)

2022

14. IMPROVED SKIN PENETRATION AND DEPOSITION OF NAFTIFINE FROM TRANSETHOSOMES AND TRANSETHOSOMAL GEL FORMULATIONS

Guzel I. E., Gungor S., Erdal M. S.

FARMACIA , vol.70, no.3, pp.514-521, 2022 (SCI-Expanded)

2022

15. Posaconazole micelles for ocular delivery: in vitro permeation, ocular irritation and antifungal activity studies

Durgun M. E., Kahraman E., Hacioglu M., Gungor S., Ozsoy Y.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH , vol.12, no.3, pp.662-675, 2022 (SCI-Expanded)

2022

16. Nanocrystal Technology: Increasing Oral Bioavailability of Low-Soluble Drugs

Erginer Y., Pirinçci Tok Y., Güngör S.

Istanbul University Institute of Health Sciences Journal of Advanced Research in Health Sciences , vol.5, no.1, pp.1-12, 2022 (Peer-Reviewed Journal)

2021

17. Assessment of membrane type effects on in vitro performance of topical semi-solid products

Kocabas N. O., KAHRAMAN ŞİRİN E., GÜNGÖR S.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.64, 2021 (SCI-Expanded)

2021

18. Dermal delivery and follicular targeting of adapalene using PAMAM dendrimers.

Gökçe B. B., Boran T., Emlik Çalık F., Özhan G., Sanyal R., Güngör S.

Drug delivery and translational research , vol.11, no.1, pp.626-646, 2021 (SCI-Expanded, Scopus)

2021

19. Nanocarriers Mediated Cutaneous Drug Delivery

Güngör S., Kahraman E.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.158, 2021 (SCI-Expanded)

2021

20. Silk-fibroin-containing nanofibers for topical sertaconazole delivery: preparation, characterization, and antifungal activity

Esenturk I., Gumrukcu S., Sert A. B. O., Kök F. N., DÖŞLER S., GÜNGÖR S., et al.

INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS , vol.70, no.9, pp.605-622, 2021 (SCI-Expanded)

2021

21. Design and characterisation of colloidal nanocarriers for enhanced skin delivery of etodolac

Saribey G., Kahraman E., ERDAL M. S., GÜNGÖR S.

Journal of Research in Pharmacy , vol.25, no.1, pp.22-33, 2021 (ESCI)

2020

22. A Solid Ultra Fine Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) of Deferasirox for Improved Solubility: Optimization, Characterization, and In Vitro Cytotoxicity Studies

Alghananim A., Özalp Y., Mesut B., Serakinci N., Özsoy Y., Güngör S.

PHARMACEUTICALS , vol.13, no.8, 2020 (SCI-Expanded)

2020

23. Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.

Durgun M., Güngör S., Özsoy Y.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics , vol.36, pp.323-341, 2020 (SCI-Expanded)

2020

24. Design of skin-simulating nanoformulations for ceramide replacement in the skin: a preliminary study

Bektay H. Ş., Kahraman E., Güngör S.

Macedonian Pharmaceutical Bulletin , vol.66, no.1, pp.101-102, 2020 (Peer-Reviewed Journal)

2020

25. **Voriconazole incorporated nanofiber formulations for topical application: preparation, characterization and antifungal activity studies against Candida species.**

Esenturk I., Balkan T., Ozhan G., Doesler S., Gungor S., Erdal M. S., et al.

Pharmaceutical development and technology , vol.25, no.4, pp.440-453, 2020 (SCI-Expanded, Scopus)

2020

26. Recent Approaches on Novel Topical Delivery Systems for Atopic Dermatitis Treatment.

Kahraman E., Aydilek N., Güngör S.

Recent patents on drug delivery & formulation , vol.14, pp.191-200, 2020 (Scopus)

2020

27. Optimization and Characterization of Aqueous Micellar Formulations for Ocular Delivery of an Antifungal Drug, Posaconazole

Durgun M., Kahraman E., Güngör S., Özsoy Y.

CURRENT PHARMACEUTICAL DESIGN , vol.26, no.14, pp.1543-1555, 2020 (SCI-Expanded)

2020

28. Effects of polyvinylpyrrolidone and ethyl cellulose in polyurethane electrospun nanofibers on morphology and drug release characteristics Elektro-eğirme yöntemi ile üretilen poliüretan nanoliflerin morfolojileri ve ilaç salım özellikleri üzerinde polivinilpirolidon ve etil selülozun etkileri

Gençtürk A., Kahraman E., GÜNGÖR S., Özsoy Y., Saraç A. S.

Turkish Journal of Pharmaceutical Sciences , vol.17, no.6, pp.638-644, 2020 (ESCI)

2020

29. In vitro skin permeation and antifungal activity of naftifine microemulsions Naftifin mikroemülsiyonlarının in vitro deriden permeasyonu ve antifungal aktivitesi

Erdal M. S., Gürbüz A., Birteksöz T., Güngör S., Özsoy Y.

Turkish Journal of Pharmaceutical Sciences , vol.17, no.1, pp.43-48, 2020 (ESCI)

2019

30. Recent Advances on Topical Application of Ceramides to Restore Barrier Function of Skin

Kahraman E., Kaykin M., Bektay H. S., GÜNGÖR S.

COSMETICS , vol.6, no.3, 2019 (ESCI)

2019

31. Formulation and in vitro Characterization of Transethosomes for Dermal Drug Delivery

Gürbüz A., Güngör S., Erdal M. S.

Sağlık Bilimlerinde İleri Araştırmalar Dergisi , vol.2, no.2, pp.51-59, 2019 (Peer-Reviewed Journal)

2018

32. Voriconazole and sertaconazole loaded colloidal nano-carriers for enhanced skin deposition and improved topical fungal treatment

Qurt M. S., Esenturk I., Tan S. B., Erdal M. S., Araman A., Gungor S.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.48, pp.215-222, 2018 (SCI-Expanded)

2018

33. The combination of nanomicelles with terpenes for enhancement of skin drug delivery

Kahraman E., NEŞETOĞLU N., GÜNGÖR S., ÜNAL D. Ş., Özsoy Y.

International Journal of Pharmaceutics , vol.551, pp.133-140, 2018 (SCI-Expanded)

2018

34. Overview on nanotechnology based cosmeceuticals to prevent skin aging

Otlatici G., Yegen G., Gungor S., Aksu B.

ISTANBUL JOURNAL OF PHARMACY , vol.48, no.2, pp.55-62, 2018 (ESCI)

2017

35. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery

Kahraman E., Gungor S., Ozsoy Y.

THERAPEUTIC DELIVERY , vol.8, no.11, pp.967-985, 2017 (ESCI)

2017

36. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.

Gungor S., REZIGUE M.

Current drug metabolism , vol.18, pp.454-468, 2017 (SCI-Expanded)

2017

37. Development and in vitro characterization of microemulsions of isotretinoin

GÜRBÜZ A., GÜNGÖR S., ERDAL M. S.

Acta Pharmaceutica Sciencia , vol.55, no.2, pp.17-32, 2017 (Scopus)

2016

38. Polymeric micellar nanocarriers of benzoyl peroxide as potential follicular targeting approach for acne treatment

Kahraman E., ÖZHAN G., Özsoy Y., GÜNGÖR S.

Colloids and Surfaces B: Biointerfaces , vol.146, pp.692-699, 2016 (SCI-Expanded, Scopus)

2016

39. Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations

Erdal M. S., Ozhan G., Mat M. C., Ozsoy Y., Gungor S.

INTERNATIONAL JOURNAL OF NANOMEDICINE , vol.11, pp.1027-1037, 2016 (SCI-Expanded, Scopus)

2015

40. Colloidal carriers of isotretinoin for topical acne treatment: skin uptake, ATR-FTIR and in vitro cytotoxicity studies

Gurbuz A., Ozhan G., Gungor S., Erdal M. S.

ARCHIVES OF DERMATOLOGICAL RESEARCH , vol.307, no.7, pp.607-615, 2015 (SCI-Expanded, Scopus)

2015

41. Biopolymer-Based Transdermal Films of Donepezil as an Alternative Delivery Approach in Alzheimer's Disease Treatment

Galipoglu M., Erdal M. S., Gungor S.

AAPS PHARMSCITECH , vol.16, no.2, pp.284-292, 2015 (SCI-Expanded)

2014

42. Optimization of Biopolymer Based Transdermal Films of Metoclopramide as an Alternative Delivery Approach

Aktar B., Erdal M. S., Sagirli O., Gungor S., Ozsoy Y.

POLYMERS , vol.6, no.5, pp.1350-1365, 2014 (SCI-Expanded)

2014

43. Design and Evaluation of Polysaccharide-Based Transdermal Films for the Controlled Delivery of Nifedipine

Bektas A., Cevher E., Gungor S., Ozsoy Y.

CHEMICAL & PHARMACEUTICAL BULLETIN , vol.62, no.2, pp.144-152, 2014 (SCI-Expanded)

2013

44. Transdermal flux predictions for selected selective oestrogen receptor modulators (SERMs): Comparison with experimental results

Gungor S., Delgado-Charro M. B., Masini-Eteve V., Potts R. O., Guy R. H.

JOURNAL OF CONTROLLED RELEASE , vol.172, no.3, pp.601-606, 2013 (SCI-Expanded)

2013

45. Geriatride Kullanılan Dozaj Şekilleri

GÜNGÖR S.

Türkiye Klinikleri Eczacılık Bilimleri Dergisi , vol.2, no.1, pp.12-20, 2013 (Peer-Reviewed Journal)

2013

46. Optimization and Characterization of Chitosan Films for Transdermal Delivery of Ondansetron

Can A. S., Erdal M. S., Gungor S., Ozsoy Y.

MOLECULES , vol.18, no.5, pp.5455-5471, 2013 (SCI-Expanded)

2013

47. New Formulation Strategies in Topical Antifungal Therapy Vol. No.

GÜNGÖR S.

Journal of Cosmetics, Dermatological Sciences and Applications , vol.3, pp.56-65, 2013 (Peer-Reviewed Journal)

2012

48. Systemic delivery of antihypertensive drugs via skin

GÜNGÖR S., Özsoy Y.

Therapeutic Delivery , vol.3, no.9, pp.1101-1116, 2012 (ESCI)

2012

49. Plasticizers in Transdermal Drug Delivery Systems

Gungor S., Erdal M. S., Ozsoy Y.

RECENT ADVANCES IN PLASTICIZERS , pp.91-112, 2012 (SCI-Expanded)

2011

50. Nasal route: an alternative approach for antiemetic drug delivery

Ozsoy Y., Gungor S.

EXPERT OPINION ON DRUG DELIVERY , vol.8, no.11, pp.1439-1453, 2011 (SCI-Expanded)

2011

51. Biophysical methods used to assess the structure and the permeability of skin Derinin yapisinin aydinlatilmasi ve geçirgenliǧinin deǧerlendirilmesinde kullanilan biyofiziksel yöntemler

GÜNGÖR S., ERDAL M. S., Özdin D.

Turkiye Klinikleri Dermatoloji , vol.21, no.1, pp.25-39, 2011 (Scopus)

2010

52. Ondansetron-loaded biodegradable microspheres as a nasal sustained delivery system: In vitro/in vivo studies

Gungor S., Okyar A., Erturk-Toker S., Baktir G., Ozsoy Y.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , vol.15, no.3, pp.258-265, 2010 (SCI-Expanded)

2009

53. ATR-FTIR SPECTROSCOPIC ANALYSIS OF THE EFFECT OF TERPENE/CO-SOLVENT MIXTURES ON PIG SKIN

Erdal M. S., Ozdin D., Gungor S.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.38, no.1, pp.147-149, 2009 (SCI-Expanded)

2008

54. Matrix-type transdermal patches of verapamil hydrochloride: In vitro permeation studies through excised rat skin and pharmacodynamic evaluation in rats

Guengoer S., Bektas A., Alp F. I., Uydes-Dogan B. S., Oezdemir O., Araman A., et al.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , vol.13, no.4, pp.283-289, 2008 (SCI-Expanded)

2004

55. Vehicle effects on in vitro release of tiaprofenic acid from different topical formulations

Özsoy Y., GÜNGÖR S., CEVHER E.

Farmaco , vol.59, no.7, pp.563-566, 2004 (Scopus)

2004

56. Vehicle effects on in vitro release of tiaprofenic acid from different topical formulations.

ÖZSOY ERGİNER Y., GÜNGÖR S., CEVHER E., ARAMAN A. O.

IL Farmaco , no.59, pp.563-566, 2004 (Peer-Reviewed Journal)

2003

57. In vitro studies on sustained release suppository formulations of tiaprofenic acid with sucre fatty acid ester

GÜNGÖR S., Orlu M., ÖZSOY ERGİNER Y., ARAMAN A. O.

SCIENTIA PHARMACEUTICA , no.71, pp.357-364, 2003 (Scopus)

2003

58. Investigations on mefenamic acid sustained release tablets with water-insoluble gel

GÜNGÖR S., YILDIZ A., Özsoy Y., CEVHER E., ARAMAN A. O.

Farmaco , vol.58, no.5, pp.397-401, 2003 (SCI-Expanded)

1997

59. Öksüz ilaçlar (Orphan Drugs)

ERGİNER Y., GÜNGÖR S.

Aktüel Eczacı , vol.37, pp.25-30, 1997 (Non Peer-Reviewed Journal)

1995

60. Comparison of paracetamol suppositories commercially available in Turkey

ARAMAN A. O., ÖZSOY ERGİNER Y., GÜNGÖR S.

Acta Pharmaceutica Turcica , vol.37, no.4, pp.130-133, 1995 (Peer-Reviewed Journal)

1994

61. Investigation of the suppository base SF-9265 prepared in Turkey

ÖZSOY ERGİNER Y., ARAMAN A. O., GÜNGÖR S.

Acta Pharmaceutica Turcica , vol.36, no.4, pp.96-101, 1994 (Peer-Reviewed Journal)

Papers Presented at Peer-Reviewed Scientific Conferences

2025

1. Optimization of Vasoconstrictor Assay for Evaluation of Bioequivalence of 0.1% Mometasone Furoate Ointment

Kahraman Şirin E., Pelvanoğlu P., Sarıbey G., Erdal M. S., Güngör S.

Skin Forum 2025, Berlin, Germany, 24 - 25 June 2025, pp.82, (Summary Text)

2024

2. The Preliminary Studies on Nasal in-situ Gels Containing Permeation Enhancers

Pelvanoğlu P., Kahraman Şirin E., Güngör S.

21st International Pharmaceutical Technology Symposium (IPTS), Ankara, Turkey, 9 - 11 September 2024, pp.223-225, (Summary Text)

2022

3. FORMULATION AND EVALUATION OF TRANSETHOSOMAL GELS CONTAINING FLUVASTATIN SODIUM FOR PSORIASIS

Gürbüz A., Güngör S., Erdal M. S.

20th International Pharmaceutical Technology Symposium (IPTS), 21 - 23 February 2022, pp.187-189, (Full Text)

2022

4. α-Bisabolol and isoconazole co-loaded liposomes for antifungal drug delivery

Şahin Bektay H., Çakmak S. M., Kahraman Şirin E., Mataracı Kara E., Güngör S.

20th International Pharmaceutical Technology Symposium, Ankara, Turkey, 21 - 23 February 2022, pp.87-88, (Full Text)

2021

5. In vitro characterization of micelles based drug delivery systems for ocular fungal infections

Durgun M. E., Mesut B., Güngör S., Erginer Y.

CRS Virtual Annual Meeting 2021, 25 - 29 July 2021, (Unpublished)

2021

6. Fluvastatin Sodium Loaded Nanovesicular Carriers: Formulation Development, Characterization and In vitro Cell Culture Studies

Gürbüz A., Güngör S., Müftüoğlu M., Ekmekçioğlu A., Erdal M. S.

CRS 2021 Virtual Annual Meeting, 25 - 29 July 2021, pp.3576185, (Summary Text)

2021

7. Pickering emulsions stabilized by cyclodextrin derivatives for treatment of atopic dermatitis: Optimization and in vitro characterization

Aydilek N., Kahraman E., Güngör S.

13th International Symposium on Pharmaceutical Sciences (ISOPS-13), Ankara, Turkey, 22 - 25 June 2021, pp.1-2, (Full Text)

2021

8. Development of the Micellar Based Ocular In Situ Gelling Systems of Posaconazole with Quality by Design (QbD) Approach

Durgun M. E., Mesut B., Güngör S., Erginer Y.

13th International Symposium on Pharmaceutical Sciences (ISOPS), 22 - 25 June 2021, pp.41-42, (Full Text)

2020

9. Development of a Solid-Type IV Self-Emulsifying Drug Delivery System of BCS Class II Drug

HUSUZADE G., MESUT B., GÜNGÖR S.

1st International Electronic Conference on Pharmaceutics, 1 - 15 December 2020, (Summary Text)

2020

10. Development of a Solid Self-Emulsifying Drug Delivery System of a Weakly Basic BCS Class II Drug

Husuzade G., Mesut B., Güngör S.

The 1st International Electronic Conference on Pharmaceutics , 1 - 15 December 2020, pp.1, (Summary Text)

2020

11. PRE-FORMULATION STUDY FOR NANOEMULSION PREPARATION OF ESSENTIAL OILS FOR TREATMENT OF CANDIDIASIS

Shahbaz A., Özalp Y., Alghananim A., Kartal M., Altanlar N., Şimşek D., et al.

The 6th International Mediterranean Symposium on Medicinal and Aromatic Plants-, İzmir, Turkey, 15 October - 17 November 2020, pp.1-2, (Full Text)

2020

12. D-α-tocopheryl Polyethylene Glycol 1000 Succinate (TPGS) Micelles Based In Situ Gelling Systems For Ocular Anti-fungal Therapy

Durgun M. E., Güngör S., Erginer Y.

Controlled Release Society (CRS) Annual Virtual Meeting 2020, 29 June - 02 July 2020, pp.1, (Summary Text)

2020

13. Optimization and Characterization of Posaconazole Loaded Nanomicelles for Ocular Delivery

Güngör S., Durgun Kılıç M. E., Kahraman E., Erginer Y.

XIII Spanish-Portuguese Conference on Controlled Drug Delivery, A-Coruna, Spain, 22 - 24 January 2020, pp.1-2, (Full Text)

2019

14. Bioequivalence assessment of generic topical gels using in vitro methods

Kalami E., Kahraman E., Dedeoğlu E., Gürbüz K., Güngör S., Özsoy Y.

8th BBBB International Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019, pp.1-2, (Summary Text)

2019

15. Nanomicellar carriers of posaconazole: A novel approach to improve its ocular bioavailability

Durgun Kılıç M. E., Kahraman E., Güngör S., Özsoy Y.

8th BBBB International Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019, pp.1-2, (Full Text)

2019

16. DEVELOPMENT, CHARACTERIZATION, AND IN VITRO SKIN STUDIES OF ULTRADEFORMABLE VESICLES

GÜRBÜZ A., GÜNGÖR S., ERDAL M. S.

8th BBBB Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019, pp.1, (Full Text)

2019

17. Preformulation Studies of Self Nanoemulsifying Drug Delivery System (SNEDDS) Formulation of Deferasirox

Alghananim A., Özalp Y., Mesut B., Güngör S., Erginer Y.

8th BBBB International Conference on Pharmaceutical Sciences , İzmir, Turkey, 14 - 16 October 2019, pp.285-286, (Full Text)

2019

18. PREPARATION AND CHARACTERIZATION OF SILK FIBROIN CONTAINING NANOFIBERS FOR SERTACONAZOLE DELIVERY

Esentürk İ., Gümrükçü S., GÜNGÖR S., ERDAL M. S., Saraç A. S.

8th BBBB Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019, pp.1, (Full Text)

2019

19. Preparation, characterization and in vitro antifungal activity of voriconazole loaded electrospun nanofibers

Esentürk İ., GÜNGÖR S., ERDAL M. S.

EUFEPS Annual Meeting 2019 PERSONALIZED MEDICINES, TARGETED THERAPIES, PRECISION DRUG DELIVERY, Frankfurt, Germany, 6 - 08 March 2019, pp.94, (Full Text)

2018

20. The Application of Artificial Neural Networks for the Development of Topical Flurbiprofen Microemulsion

Mesut B., Gürbüz A., Erdal M. S., Aksu B., Erginer Y., Güngör S.

12th Central European Symposium on Pharmaceutical Technology and Regulatory Affairs, Szeged, Hungary, 20 - 22 September 2018, pp.107-108, (Full Text)

2018

21. The Application Of Artificial Neural Networks For The Development Of Topical Flurbiprofen Microemulsions

MESUT B., ERDAL M. S., AKSU N. B., ERGİNER Y., GÜNGÖR S.

12th CESPT, 20 - 22 September 2018, (Summary Text)

2018

22. Dermal Delivery of Fluvastatin Using Nanovesicular Systems

GÜRBÜZ A., GÜNGÖR S., ERDAL M. S.

19th International Pharmaceutical Technology Symposium, Antalya, Turkey, 17 - 19 September 2018, pp.270-271, (Full Text)

2018

23. IN VITRO ANTIFUNGAL ACTIVITY OF NAFTIFINE LOADED PVA/SA NANOFIBERS

Esentürk İ., GÜNGÖR S., DÖŞLER S., Saraç A. S., ERDAL M. S.

EUFEPS Annual Meeting, Atina, Greece, 24 - 26 May 2018, pp.1, (Full Text)

2018

24. Topical nanocarriers for enhanced cutaneous delivery of voriconazole and sertaconazole

Qurt M., Esentürk İ., ERDAL M. S., GÜNGÖR S.

11th World Meeting onPharmaceutics, Biopharmaceuticsand Pharmaceutical Technology, Granada, Spain, 19 - 22 March 2018, pp.1-2, (Full Text)

2017

25. QBD Based Developement and Characterisation of Microemulsion Formulations for Improved Skin Delivery of Flurbiprofen

GÜRBÜZ A., MESUT B., ERDAL M. S., AKSU N. B., GÜNGÖR S.

2nd International GPSS Gazi Pharma Symposium Series, 11 - 13 October 2017, (Summary Text)

2017

26. QbD based development and characterization of microemulsion formulations for improved skin delivery of flurbiprofen

GÜRBÜZ A., MESUT B., ERDAL M. S., Aksu B., ERGİNER Y., GÜNGÖR S.

2nd International Gazi Pharma Symposium Series, Ankara, Turkey, 11 - 13 October 2017, pp.1, (Full Text)

2017

27. QBD-Based Development and Characterisation of Microemulsion Formulations for Improved Skin Delivery of Flurbiprofen

GÜRBÜZ A., MESUT B., ERDAL M. S., Aksu B., ERGİNER Y., GÜNGÖR S.

2nd International Gazi Pharma Symposium Series, Ankara, Turkey, 11 - 13 October 2017, pp.36, (Full Text)

2017

28. Skin penetration enhancement mechanism of mixed micelles.

KAHRAMAN E., GÜNGÖR S., Özsoy Y.

2nd International Gazi Pharma Symposium Series (GPSS-2017), Ankara, Turkey, 11 - 13 October 2017, pp.83, (Full Text)

2017

29. Flexible nano-sized vesicles as novel ocular delivery systems for voriconazole: Optimization and characterization studies.

Aksu N. B., Kalami E., KAHRAMAN E., GÜNGÖR S., Özsoy Y.

2nd International Gazi Pharma Symposium Series (GPSS-2017), Ankara, Turkey, 11 - 13 October 2017, pp.108, (Full Text)

2017

30. Sertaconazole loaded nanofibers as topical drug carriers

Esentürk İ., Güngör S., Erdal M. S.

7th BBBB International Conference on Pharmaceutical Sciences, Budapest, Hungary, 5 - 07 October 2017, pp.1, (Full Text)

2017

31. Enhanced Skin Penetration of Tacrolimus and Fucidic acid from Nano-Sized Colloidal Carriers

Güngördük S., ERDAL M. S., GÜNGÖR S.

7th BBBB International Conference on Pharmaceutical Sciences, Balatonfüred, Hungary, 5 - 07 October 2017, pp.1-2, (Full Text)

2017

32. Novel topical nano-carriers to improve penetration of tacrolimus into the skin

KAHRAMAN E., NEŞETOĞLU N., GÜNGÖR S., ÜNAL D. Ş., ERGİNER Y.

FIP World Congress of Pharmacy and Pharmaceutical Sciences 2017, Seoul, South Korea, 10 - 14 September 2017, (Full Text)

2017

33. Penetration enhancer-containing nanomicelles for topical delivery: Impact on skin barrier.

KAHRAMAN E., GÜNGÖR S., Özsoy Y.

The 44th Annual Meeting & Exposition of the Controlled Release Society, Boston, United States Of America, 16 - 19 July 2017, (Summary Text)

2017

34. Penetration Enhancer-Containing Nanomicelles for Topical Delivery: Impact on Skin Barrier

ERGİNER Y., KAHRAMAN E., GÜNGÖR S.

Controlled Release Society Annual Meeting & Exposition), Boston, United States Of America, 16 - 19 July 2017, pp.3487, (Full Text)

2017

35. Topical Nano-sized Colloidal Carriers of Tacrolimus: Development, Characterization and Skin Uptake Studies

Güngördük S., ERDAL M. S., GÜNGÖR S.

44th Annual Meeting & Exposition of the Controlled Release Society, Boston, United States Of America, 16 - 19 July 2017, pp.1, (Full Text)

2017

36. Tacrolimus loaded Pluronic F127 micelles: Cellular viability and cell growth for ocular administration

KAHRAMAN E., KARACA M., TEKARSLAN ŞAHİN Ş. H., YILDIZ PEKÖZ A., GÜNGÖR S., ERGİNER Y.

6th Pharmaceutical Sciences World Congress, Stockholm, Sweden, 21 - 24 May 2017, (Full Text)

2017

37. Tacrolimus Loaded Pluronic®F127 Micelles: Cellular Viability and Cell Growth for Ocular Administration

KAHRAMAN E., KARACA M., TEKARSLAN ŞAHİN Ş. H., YILDIZ PEKÖZ A., ERGİNER Y., GÜNGÖR S.

The 6th Pharmaceutical Sciences World Congress, Stockholm, Sweden, 21 - 24 May 2017, (Full Text)

2017

38. Electrospun Nanofibers as Topical Antifungal Drug Carriers

ERDAL M. S., Esentürk İ., GÜNGÖR S.

6th Pharmaceutical Sciences World Congress, Stockholm, Sweden, 21 - 24 May 2017, pp.1, (Full Text)

2017

39. Improving skin delivery of lipophilic compounds via enhancer-containing polymeric micelles

KAHRAMAN E., GÜNGÖR S., Özsoy Y.

6th Pharmaceutical Sciences World Congress, Stockholm, Sweden, 21 - 24 May 2017, (Summary Text)

2017

40. Fabrication and characterization of nano-micelles for topical ocular therapy

Durgun M. E., KAHRAMAN E., GÜNGÖR S., Özsoy Y.

22nd International Biomedical Science and Technology Symposium (BIOMED 2017), Ankara, Turkey, 12 - 14 May 2017, pp.85, (Summary Text)

2017

41. Nano carriers as core-shell structure for the effective treatment of skin disorders

KAHRAMAN E., GÜNGÖR S., Özsoy Y.

2nd World Conference on Technology, Innovation and Entrepreneurship "Reforms for Intellectual Economy and Innovative Entrepreneurship, İstanbul, Turkey, 12 - 14 May 2017, pp.80, (Summary Text)

2017

42. Improved drug localization in the skin via topical nano-micellar carriers

KAHRAMAN E., NEŞETOĞLU N., ÖZTAŞ E., ÖZHAN G., ÜNAL D. Ş., GÜNGÖR S., et al.

22ND INTERNATIONAL BIOMEDICAL SCIENCE & TECHNOLOGY SYMPOSIUM, Ankara, Turkey, 12 - 14 May 2017, (Full Text)

2017

43. A promising targeted approach for skin delivery

KAHRAMAN E., GÜNGÖR S., Özsoy Y.

IVEK 3rd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Turkey, 26 - 29 April 2017, pp.709, (Summary Text)

2017

44. Nano-micellar drug carriers for topical ocular administration

Durgun M. E., KAHRAMAN E., GÜNGÖR S., Özsoy Y.

IVEK 3rd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Turkey, 26 - 29 April 2017, pp.713, (Summary Text)

2016

45. development of topical micoemulsions of naftifine and evaluation of their antifungal activity

ERDAL M. S., GÜNGÖR S., BİRTEKSÖZ TAN A. S., DÖŞLER S., OZSOY Y.

the 4. Conference on: Innovation in drug delivery: ”site specific drug delivery, 25 - 28 September 2016, (Full Text)

2016

46. Development of topical microemulsions of naftifine and evaluation of their antifungal activity

ERDAL M. S., GÜNGÖR S., BİRTEKSÖZ TAN A. S., DÖŞLER S., ERGİNER Y.

4th Conference of Innovation in Drug Delivery, Antibes, France, 25 - 28 September 2016, pp.1, (Full Text)

2016

47. Optimization of Flurbiprofen microemulsions Using Artificial neural networks

MESUT B., GÜRBÜZ A., Aksu B., ERDAL M. S., GÜNGÖR S.

4th Congress on Innovation in Drug Delivery Site-Specific Drug Delivery, Antibes-Juan Les Pins, France, 25 - 28 September 2016, pp.74, (Full Text)

2016

48. Colloidal Nanocariers of flurbiprofen Physicochemical Characterisation and in vitro Skin Permeation Studies

GÜRBÜZ A., MESUT B., ERDAL M. S., GÜNGÖR S.

18 th International Pharmaceutical Technology symposium, 18 - 21 September 2016, (Summary Text)

2016

49. Colloidal Nanocarriers of Flurbiprofen: Physicochemical Characterization and In Vitro Skin Permeation Studies

GÜRBÜZ A., MESUT B., ERDAL M. S., GÜNGÖR S.

International Pharmaceutical Technology Symposium, Antalya, Turkey, 18 - 21 September 2016, pp.194-196, (Full Text)

2016

50. Transethosomal nanocarriers for enhanced skin delivery of antifungal drugs.

ERDAL M. S., Esentürk İ., GÜNGÖR S.

18th International Pharmaceutical Technology Symposium (IPTS), Antalya, Turkey, 18 - 21 September 2016, pp.1-5, (Full Text)

2016

51. Naftifine loaded electrospun nanofibers as topical drug carriers

Esentürk İ., GÜNGÖR S., ERDAL S.

Skin Forum Annual Meeting, Londra, United Kingdom, 21 - 22 June 2016, pp.1, (Summary Text)

2016

52. Preliminary Studies on Topical Polymeric Micellar Formulations of Immunomodulatory Drugs

KAHRAMAN E., GÜNGÖR S., ÖZSOY Y.

Skin Forum 15th Annual Meeting, Londra, United Kingdom, 21 - 22 June 2016, pp.1-2, (Summary Text)

2016

53. Voriconazole loaded electrospun nanofibers as topical drug carriers

ERDAL M. S., Esentürk İ., Balkan T., GÜNGÖR S., Saraç A. S.

7th European Dermatology Congress, Alicante, Spain, 13 - 14 June 2016, pp.1, (Summary Text)

2016

54. Transdermal Iontophoresis: A Non-Invasive Drug Delivery Approach for Alzheimer's Disease

GÜNGÖR S.

World Congress & Expo on Pharmaceutics & Drug Delivery Systems (Pharmaceutics-2016), Dubai, United Arab Emirates, 21 - 23 April 2016, pp.1, (Summary Text)

2016

55. Colloidal Nano-carriers for the Treatment of Inflammatory Skin Diseases

GÜNGÖR S.

2nd Annual World Congress of Smart Materials-2016 (WCSM-2016), Singapur, Singapore, 4 - 06 March 2016, pp.1, (Summary Text)

2015

56. Microemulsion Formulations for the Dermal Delivery of Antifungal Drugs

Ourt M., Esentürk İ., ERDAL S., ARAMAN A. O., GÜNGÖR S.

2015 Annual Meeting and Exposition, Orlando, United States Of America, 25 - 29 October 2015, pp.1, (Full Text)

2015

57. Optimization and Characterization of Topical Microemulsions of a Calcineurin Inhibito

Güngördük S., ERDAL M. S., GÜNGÖR S.

4th BBB Bled International Conference on Pharmaceutical Sciences, Helsinki, Finland, 10 - 12 September 2015, pp.1, (Summary Text)

2015

58. Optimization of Electrospun Nanofiber Mats for Transdermal Delivery

Gençtürk A., KAHRAMAN E., ÖZHAN G., GÜNGÖR S., ERGİNER Y., Saraç A. S.

Controoled Release Society Annual Meeting 2015, Edinburgh, United Kingdom, 26 - 29 July 2015, pp.1-2, (Full Text)

2015

59. Isotretionin colloidal carriers for topical acne treatment: ATR-FTIR and in vitro cytotoxicity studies

ERDAL M. S., GÜRBÜZ A., ÖZHAN G., GÜNGÖR S.

Controlled Release Society, Edinburgh, United Kingdom, 26 - 29 July 2015, pp.1, (Full Text)

2015

60. Optimization of nano-sized topical colloidal drug carriers for treatment of atopic dermatitis

Güngördük S., ERDAL M. S., GÜNGÖR S.

Istanbul University World Conference on Technology, Innovation and Entrepreneurship, İstanbul, Turkey, 28 - 30 May 2015, pp.1, (Full Text)

2015

61. Polymeric nano-sized micelles: Targeting to hair follicles for skin diseases

KAHRAMAN E., GÜNGÖR S., Özsoy Y.

Nanobiotechnology Days 2015, İstanbul, Turkey, 14 - 15 May 2015, (Summary Text)

2015

62. Pluronic F127 micellar carriers for topical acne treatment

KAHRAMAN E., Özsoy Y., GÜNGÖR S.

1st European Cenference on Pharmaceutics Drug Delivery, Reims, France, 13 - 14 April 2015, pp.1-2, (Full Text)

2014

63. Micelles as nanosized carriers for skin delivery

GÜNGÖR S.

4th International Conference on Nanotek & Expo, San Francisco, United States Of America, 1 - 03 December 2014, vol.5, no.5, pp.101, (Summary Text)

2014

64. Atopik dermatit tedavisine yönelik yenilikçi topikal ilaç taşıyıcı sistemler

Güngördük S., ERDAL M. S., GÜNGÖR S.

Uluslararası İlaç ve Eczacılık Kongresi (İVEK), İstanbul, Turkey, 28 - 30 November 2014, pp.1, (Full Text)

2014

65. Novel Colloidal Drug Delivery Systems in Topical Therapy

GÜRBÜZ A., Esentürk İ., GÜNGÖR S., ERDAL M. S.

İlaç ve Eczacılık Kongresi, İstanbul, Turkey, 28 - 30 November 2014, pp.40, (Full Text)

2014

66. VEHICLE COMPOSITION EFFECTS ON IN VITRO TRANSSCLERAL IONTOPHORETIC TRANSPORT OF MOXIFLOXACIN

MESUT B., ERGİNER Y., GÜNGÖR S.

17th International Pharmaceutical Technology Symposium, Antalya, Turkey, 8 - 10 September 2014, pp.294-296, (Full Text)

2014

67. Optimization and characterization of transethosomes for topical delivery of a highly lipophilic antifungal drug

ERDAL M. S., Esentürk İ., GÜNGÖR S.

Skin Forum 14th Annual Meeting- Percutaneous penetration, measurement, modulation and modelling, Prague, Czech Republic, 4 - 05 September 2014, pp.1, (Full Text)

2014

68. Isotretinoin Loaded Microemulsions: Development, Characterization and In vitro Evaluation of Skin Penetration

GÜRBÜZ A., GÜNGÖR S., ERDAL M. S.

Skin Forum 14th Annual Meeting, Prag, Czech Republic, 4 - 05 September 2014, pp.63, (Full Text)

2014

69. Isotretinoin loaded microemulsions: Development, characterization and in vitro evaluation of skin penetration

GÜRBÜZ A., GÜNGÖR S., ERDAL M. S.

Skin Forum 14th Annual Meeting- Percutaneous penetration, measurement, modulation and modelling, Prague, Czech Republic, 4 - 05 September 2014, pp.1, (Full Text)

2014

70. IN VITRO TRANSSCLERAL IONTOPHORESIS OF MOXIFLOXACIN HYDROCHLORIDE

MESUT B., ERGİNER Y., GÜNGÖR S.

41st Annual Meeting & Exposition of the Controlled Release Society, Chicago, United States Of America, 13 - 16 July 2014, pp.125, (Full Text)

2014

71. Polymeric micellar nanocarriers: Improved chemical stability and enhanced skin deposition of anti-acne drugs

KAHRAMAN E., Özsoy Y., GÜNGÖR S.

World Congress of the International Society for Biophysics and Imaging of the Skin (ISBS): Emerging Measurements Meets the Cutting Edge in Medicine, Connecticut, United States Of America, 2 - 04 June 2014, (Summary Text)

2014

72. Improved skin penetration and distribution of two antifungal compounds using new topical carriers

ERDAL M. S., GÜNGÖR S.

World Congress of the International Society for Biophysicsand Imaging of the Skin (ISBS), Connecticut, United States Of America, 1 - 04 June 2014, pp.1, (Full Text)

2014

73. Optimisation and characterisation studies on topical microemulsion formulations of etodolac.

Sarıbey G., ERDAL M. S., GÜNGÖR S.

9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Lizbon, Portugal, 31 March - 03 April 2014, pp.1-2, (Full Text)

2013

74. Potential nanocarriers for topical skin delivery of drugs

GÜNGÖR S.

3rd International Conference on Nanotek & Expo, NANOTEK-2013, Las Vegas, United States Of America, 2 - 04 December 2013, (Summary Text)

2013

75. Combined dual chambered topical preparation in acne treatment.

GÜNGÖR S., KAYTANLIOĞLU L., ERDAL M. S., ÖZSOY Y., Embil K.

ISBS/SICC 1st JOINT INTERNATIONAL CONGRESS, Milano, Italy, 15 - 16 October 2013, (Full Text)

2012

76. In vitro evaluation of isotretinoin loaded microemulsions with ATR-FTIR Spectroscopy and tape stripping.

GÜNGÖR S.

World Congress of the International Society for Biophysics & Imaging of the Skin (ISBS), Denmark, 1 - 04 November 2012, (Summary Text)

2012

77. Uptake of Naftifine Hydrochloride Microemulsions into the Stratum Corneum and Their Impact on Skin Barrier

GÜNGÖR S.

16. International Pharmaceutical Technology Symposium, Turkey, 1 - 04 September 2012, (Full Text)

2012

78. In vitro permeation of donepezil hydrochloride from transdermal films.

GÜNGÖR S., ERDAL M. S.

The 39th Annual Meeting of Controlled Release Society, Quebec City, Canada, July , 2012., Canada, 1 - 04 July 2012, (Full Text)

2012

79. Effect of Terpene-Transcutol mixtures on the enhanced topical delivery of naftifine hydrochloride.

GÜNGÖR S., ERDAL M. S.

The 39th Annual Meeting of Controlled Release Society,, Canada, 1 - 04 July 2012, (Full Text)

2012

80. Comparison of topical gel formulations containing flurbiprofen.

GÜNGÖR S., ERDAL M. S.

The 13th Perspectives on Percutaneous Penetration, Thirteenth International Conference, France, 1 - 04 April 2012, (Full Text)

2012

81. Matrix type chitosan transdermal films of ondansetron.

GÜNGÖR S., ERDAL M. S.

8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Turkey, 1 - 04 March 2012, (Full Text)

2011

82. Iontophoretic delivery of ondansetrone HCI in vitro: Contribution of electromigration and electroosmosis

GÜNGÖR S., Özdin D.

38th Annual Meeting of Controlled Release Society, Maryland, United States Of America, 30 July - 03 August 2011, pp.1-2, (Full Text)

2011

83. Development of matrix type transdermal formulations of ondansetron hydrochloride with natural polymers

Can A. S., ERDAL M. S., GÜNGÖR S., Özsoy Y.

10th International Conference of the European Chitin Society, St. Petersburg, Russia, 20 - 24 May 2011, pp.1, (Full Text)

2010

84. Development of matrix type transdermal formulations of ondansetron hydrochloride with natural polymers

Can A. S., ERDAL M. S., GÜNGÖR S., Özsoy Y.

10th International Conference of the European Chitin Society, St. Petersburg, Russia, 13 - 15 September 2010, pp.1, (Full Text)

2010

85. Design of microemulsion type colloidal carrier systems of naftifine hydrochloride

ERDAL M. S., GÜNGÖR S., Özsoy Y.

International Pharmaceutical Technology Symposium (IPTS), Antalya, Turkey, 13 - 15 September 2010, pp.1, (Full Text)

2009

86. ATR-FTIR Spectroscopic analysis of the effect of terpene/co-solvent mixtures on pig skin

ERDAL M. S., Özdin D., GÜNGÖR S.

3rd BBBB International Conference on Pharmaceutical Sciences, Antalya, Turkey, 26 - 28 October 2009, pp.147-149, (Full Text)

2009

87. In vitro evaluation of indomethacin loaded solid lipid microparticles

ERDAL M. S., GÜNGÖR S., ERGİNER Y., ARAMAN A. O.

17th International Symposium on Microencapsulation, Nagoya, Japan, 29 September - 01 October 2009, pp.1, (Full Text)

2009

88. Evaluation of penetration enhancement effect of terpenes on a highly lipophilic compound with ATR-FTIR spectroscopy

ERDAL M. S., ERGİNER Y., GÜNGÖR S.

69th FIP World Congree of Pharmacy and Pharmaceutical Sciences, İstanbul, Turkey, 3 - 08 September 2009, pp.1, (Full Text)

2009

89. Preliminary In vitro Studies on Transdermal Patches of Metoclopramide Hydrochloride

ERGİNER Y., AKTAR B., GÜNGÖR S.

2nd PharmSciFair. Premier European Platform for Advancing Pharmaceutical Sciences, Nice, France, 8 - 12 June 2009, pp.1, (Full Text)

2007

90. Düşük Molekül Ağırlıklı Heparinin Jel Formülasyonları Üzerine In-Vitro Çalışmalar

ERGİNER Y., YILDIZ PEKÖZ A., GÜNGÖR S., ARAMAN A. O.

VII. Ulusal Tromboz, Hemostaz ve Anjioloji Kongresi, Adana, Turkey, 4 - 06 May 2007, pp.1, (Full Text)

2007

91. in vitro and in vivo studies on ondansetron HCl loaded biodegradable mıcrospheres

ERGİNER Y., GÜNGÖR S., OKYAR A., TOKER S., Baktır G.

Pharmaceutical Sciences World Congress, Amsderdam, Netherlands, 22 - 25 April 2007, pp.1, (Full Text)

2005

92. Effects of terpenes on Verapamil HCl permeation through excised rat skin from matrix-type transdermal systems and pharmacodynamic activity

GÜNGÖR S., Bektaş A., ALP F. İ., ÖZSOY ERGİNER Y., UYDEŞ DOĞAN B. S., ARAMAN A. O., et al.

Pharmaceutical Sciences Fair& Exhibition, EUFEPS, Nice, France, 12 - 17 June 2005, pp.1, (Full Text)

2005

93. Effect of terpenes on verapamil hydrochloride permeation through excised rat skin from matrix-type transdermal systems and pharmacodynamic activity in rats

ERGİNER Y., GÜNGÖR S., BEKTAŞ A., ALP YILDIRIM F. İ., UYDEŞ DOĞAN B. S., ÖZDEMİR O., et al.

PharmSciFair, Pharmaceutical Sciences Fair & Exhibition, Nice, France, 12 - 17 June 2005, pp.1, (Full Text)

2003

94. In vitro studies on topical gel formulations of low molecular weight heparin

ERGİNER Y., YILDIZ PEKÖZ A., GÜNGÖR S., ARAMAN A. O.

Symposium Skin and Formulation, Paris, France, 23 - 24 October 2003, pp.1, (Full Text)

2003

95. Preliminary in vitro studies on transdermal matrix formulations of verapamil hydrochloride using pectin

ERGİNER Y., GÜNGÖR S., BEKTAŞ A., ARAMAN A. O.

Symposium Skin and Formulation, Paris, France, 23 - 24 October 2003, pp.1, (Full Text)

2002

96. Studies on indomethacin loaded microparticles with glyceryl behenate

ERGİNER Y., ERDAL M. S., GÜNGÖR S., ARAMAN A. O.

3rd International Postgraduate Research Symposium on Pharmaceutics, İstanbul, Turkey, 16 - 18 September 2002, pp.1, (Full Text)

2002

97. Studies on topical formulations of tiaprofenic acid

ERGİNER Y., GÜNGÖR S., CEVHER E.

3rd International Postgraduate Research Symposium on Pharmaceutics, İstanbul, Turkey, 16 - 18 September 2002, pp.1, (Full Text)

2002

98. Preliminary Studies on Sustained Release Suppository Formulations of Tiaprofenic Acid with Sucrose Ester

ERGİNER Y., GÜNGÖR S., ORLU M., ARAMAN A. O.

11th International Pharmaceutical Technology Symposium, İstanbul, Turkey, 9 - 11 September 2002, pp.1, (Full Text)

2000

99. Investigations on Mefenamic Acid Sustained-Release Tablets with Water-Insoluble Gel

ERGİNER Y., YILDIZ PEKÖZ A., GÜNGÖR S., CEVHER E., ARAMAN A. O.

The Second International Postgraduate Research Symposium on Pharmaceutics, İstanbul, Turkey, 6 - 08 September 2000, pp.1, (Full Text)

Books

2025

1. Nano-based nasal delivery of biomacromolecules: a myriad of opportunities

Sinani G., Güngör S., Erginer Y., Cevher E.

in: Bioactive‐Based Nanotherapeutics, Rakesh K. Sindhu (Editor),Sumitra Singh (Editor),Evren Algin Yapar (Editor), Editor, John Wiley & Sons Inc, New Jersey, pp.151-198, 2025

2025

2. Nanocrystals Based Approach in Colon Targeting

Pirinçci Tok Y., Güngör S., Erginer Y.

in: Nanocarriers Based Colon Targeting Design, Development, Mechanism and Case Studies, Lalit Kumar,Yashwant Pathak, Editor, Academic Press , London, pp.569-600, 2025

2025

3. Self nanoemulsifying drug delivery systems in colon targeting

Demiralp B., Al-Mohaya M., Çelik Y. S., Güngör S., Erginer Y.

in: Nanocarriers Based Colon Targeting, Lalit Kumar,Yashwant V. Pathak, Editor, Elsevier Science, Oxford/Amsterdam , Massachusetts, pp.689-716, 2025

2023

4. Nasal Delivery of High Molecular Weight Drugs: Recent Trends and Clinical Evidence

Kahraman Şirin E., Güngör S., Erginer Y.

in: Nasal Drug Delivery, Yashwant V. Pathak,Hemant K. S. Yadav, Editor, Springer Nature, Basel, pp.253-277, 2023

2022

5. Polymeric micellar nanocarriers: topical treatment of inflammatory diseases

Kahraman Şirin E., Durgun M. E., Güngör S., Erginer Y.

in: Polymeric Micelles for Drug Delivery, Prashant Kesharwani,Khaled Greish, Editor, Elsevier Science, Oxford/Amsterdam , Amsterdam, pp.115-143, 2022

2022

6. Drug Release, Susceptibility and Time-Kill Assays to Develop Novel Anti-Infective Drugs

Esentürk Güzel İ., Durgun M. E., Güngör S., Erginer Y.

in: Encyclopedia of Infection and Immunity, Nima Rezaei,Rowena Jenkins,Fanny Lanternier,Fernando Cobo,Fabrizio Bruschi,Giovanni Benelli,Federico Iovino,Hans D. Ochs, Editor, Elsevier Science, Oxford/Amsterdam , Oxford, pp.640-651, 2022

2022

7. Herbal bioactives for ocular drug delivery systems

Alğın Yapar E., Durgun M. E., Esentürk İ., Güngör S., Erginer Y.

in: Herbal Bioactive-Based Drug Delivery Systems Challenges and Opportunities, Inderbir Bakshi,Rajni Bala,Reecha Madaan,Rakesh Sindhu, Editor, Elsevier Science, Oxford/Amsterdam , Oxford, pp.25-61, 2022

2021

8. Frontiers in Anti-infective Agents

Durgun Kılıç M. E., Güngör S., Erginer Y.

Bentham Science Publishing, Singapore, 2021

2021

9. Oküler Tedavide Anti-enfektif Ajanlar ve Yeni Yaklaşımlar

Durgun M. E., Güngör S., Erginer Y.

in: Frontiers in Anti-infective Agents, Singh P.,Kumar V.,Karpoormath R., Editor, Bentham Science Publishers, Singapore, pp.1-41, 2021

2021

10. Anti-Infective Agents in Ocular Treatment and New Approaches

Durgun M. E., Güngör S., Erginer Y.

in: Frontiers in Anti-infective Agents, Singh P.,Kumar V.,Karpoormath R., Editor, Bentham Science Publishers, Singapore, pp.1-41, 2021

2020

11. Electrospun Nanofibers as Carriers in Dermal Drug Delivery

Erdal M. S., Güngör S.

in: Nanopharmaceuticals: Principles and Applications Vol. 3. Environmental Chemistry for a Sustainable World, Yata V.,Ranjan S.,Dasgupta N.,Lichtfouse E, Editor, Springer, London/Berlin , Zug, pp.139-163, 2020

2020

12. Recent advances in biopolymer-based transdermal patches

Güngör S., Kahraman E., Erdal M. S., Özsoy Y.

in: Biopolymer Membranes and Films, Health, Food, Environment, and Energy Applications, Mariana Agostini de Moraes,Classius Ferreira da Silva,Rodrigo Silveira Vieira, Editor, Elsevier Science, Oxford/Amsterdam , Chennai, pp.195-217, 2020

2020

13. Nanocarrier-mediated follicular targeting

Gökçe B. B., Güngör S.

in: Nanocosmetics- Fundamentals, Applications and Toxicity Micro and Nano Technologies, Arun Nanda,Sanju Nanda,Tuan Anh Nguyen,Susai Rajendran,Yassine Slimani Nanocosmetics, Editor, Elsevier bedrijfsinformatie , Chennai, pp.305-326, 2020

2019

14. Phytosomes as Novel Carriers of Herbal Extracts

Güngör S., Akbal Dağıstan Ö., Algın Yapar E., Kartal M., Erginer Y.

in: Novel Drug Delivery Systems for Phytoconstituents, Gupta M,Chauhan D.A.,Sharma V,Chauhan N.S., Editor, Crc Press, Florida, pp.69-81, 2019

2019

15. Polymeric micelles as a novel carrier for ocular drug delivery

Özsoy Y., Güngör S., Kahraman E., Durgun M. E.

in: Nanoarchitectonics in Biomedicine, Grumezescu AM, Editor, William Andrew Publishing , New York, pp.85-117, 2019

2017

16. EczÇEP-Eczacılık Fakülteleri Müfredat Detay Çalışması

Akalın E., Akev N., Erginer Y., Güzeldemirci N., Toker S., Kolak U., et al.

Kapitta Yayıncılık, Ankara, 2017

2017

17. EczÇEP- Eczacılık Fakülteleri Müfredat Detay Çalışması

Akalın Uruşak E., Akev N., Erginer Y., Güzeldemirci N., Toker S., Kolak U., et al.

Kapitta Yayıncılık, Ankara, 2017

2016

18. Nanocarriers of Antifungal Agents

GÜNGÖR S., ERDAL M. S.

in: Recent Trends in Antifungal Agents and Antifungal Therapy, Basak, Amit, Chakraborty, Ranadhir, Mandal, Santi M. , Editor, Springer-Verlag , Heidelberg, pp.1-19, 2016

2016

19. Dermal and Transdermal Drug Delivery Systems

GÜNGÖR S., ERDAL M. S., ERGİNER Y.

in: Encyclopedia of Biomedical Polymers and Polymeric Biomaterials, Munmaya KM., Editor, Taylor And Francis, New York, pp.2606-2619, 2016

2015

20. Colloidal carriers in the topical treatment of dermatological diseases

GÜNGÖR S., ERDAL M. S., Güngördük S.

in: Nano Based Drug Delivery, Naik J., Editor, Iapc Bookhome Publishing, Zagreb, pp.391-409, 2015

2015

21. Polymeric micelles for cutaneous drug delivery

GÜNGÖR S., KAHRAMAN E., ERGİNER Y.

in: Nano Based Drug Delivery, Naik J., Editor, Iapc Publishing, Zagreb, pp.369-384, 2015

2014

22. Topikal Uygulanan Nanotaşıyıcılar

GÜNGÖR S.

in: Nanofarmasötikler ve Uygulamaları, Zırh-Gürsoy A., Editor, Aktif Matbaa Ve Reklam Hizmetleri San. Tic Ltd. Şti, İstanbul, pp.333-345, 2014

2014

23. Synergistic Effects of Transcutol and Terpenes as Penetration Enhancers: In vitro and In vivo ATR-FTIR Spectroscopic Imaging Studies

ERDAL M. S., Özdin D., GÜNGÖR S.

in: Advanced Dermatological Sciences, Chicott R. and Brain K., Editor, Uk Royal Soicety Of Chemistry Cambridge, Uk, Cambridge, pp.100-110, 2014

2012

24. Plasticizers in Transdermal Delivery Systems

GÜNGÖR S., ERDAL M. S., ERGİNER Y.

in: Plasticizers, Luqman M., Editor, Intech, Rijeka, pp.91-112, 2012

2012

25. Polymeric nanoparticles applied via nasal route.

ERGİNER Y., YILDIZ PEKÖZ A., GÜNGÖR S.

in: Polymeric nanoparticles applied via nasal route., Şenyiğit T., Özcan İ., Özer Ö, Editor, Nanotechnology İn Progress: Pharmaceutical Applications,, Research Signpoint, Kerala, India, Chapter, pp.95-109, 2012

2011

26. Novel formulation approaches for topical and transdermal delivery of non-steroidal antiinflammatory drugs

OKYAR A., ERGİNER Y., GÜNGÖR S.

in: Rheumatoid Arthritis– Treatment, Lemmey A., Editor, Intech, Rijeka, pp.25-48, 2011

Episodes in the Encyclopedia

2015

1. Encyclopedia of Biomedical Polymers and Polymer Biomaterials

Erdal M. S., Güngör S., Erginer Y.

Taylor And The Francis Press, pp.2606-2619, 2015

Other Publications

2013

1. Geriatride Kullanılan Dozaj Şekilleri

ÖZSOY Y., GÜNGÖR S., AKSU B., ARAMAN A. O.

Other, pp.12-20, 2013

Funded Projects

2022 - Present

Kompleks Jenerik İlaçların Eşdeğerliğinin Kanıtlanmasına Yönelik In vitro Yöntemlerin Geliştirilmesi ve Fizyolojik Temelli Farmakokinetik Modelleme ile In vivo In vitro Korelasyonun Değerlendirilmesi

Project Supported by Higher Education Institutions , BAP Other

GÜNGÖR S. (Executive), ERGİNER Y., AYDİLEK N., FOTAKİ N., MESUT B.

2022 - Present

Glikoprotein Yapısındaki Eritropoetinin Nazal Formülasyonları Üzerine Çalışmalar

Project Supported by Higher Education Institutions , BAP MSc

GÜNGÖR S. (Executive), YAZICI Ö.

2023 - 2025

Furosemid İçeren Kendiliğinden Emülsifiye Olabilen Lipid Formülasyonunun Geliştirilmesi ve İn Vitro Karakterizasyon Çalışmaları

Project Supported by Higher Education Institutions , BAP Other

GÜNGÖR S. (Executive), YARALI A., KÖKSOY A. B., KURUÇAY M.

2022 - 2024

Çözünürlüğü Düşük Etken Maddelerin Nanokristallerinin Tasarımla Kalite Qbd Yaklaşımı ile Optimizasyonu

Project Supported by Higher Education Institutions , BAP PhD

GÜNGÖR S. (Executive), KALAMI E.

2020 - 2024

İn Vitro Permeasyon Çalışmaları İçin Deriyi Taklit Eden Yapay Membran Modellerinin Tasarlanması

Project Supported by Higher Education Institutions , BAP PhD

GÜNGÖR S. (Executive), ŞAHİN BEKTAY H.

2021 - 2023

Oküler Uygulamaya Yönelik Antifungal Etken Madde Yüklü Polimerik Miseller ile Nanolif Sistemlerinin Geliştirilmesi Formülasyonun QbD ile Optimizasyonu Karakterizasyonu İn vitro, Ex vivo ve İn vivo Çalışmalar ile Değerlendirilmesi

Project Supported by Higher Education Institutions , BAP Other

Güngör S. (Executive), Durgun M. E., Mesut B.

2020 - 2021

Biyofarmasötik Sınıflandırma Sistemi Sınıf II Molekülün Çözünürlüğünün Arttırılması Yaklaşımı ile Lipit yapılı Nanotaşıyıcıların Geliştirilmesi

Project Supported by Higher Education Institutions , BAP MSc

GÜNGÖR S. (Executive), Husuzade G.

2018 - 2020

Vitamin D ve PRP İçeren Biyouyumlu Taşıyıcıların Sıçan Kalvaryasında Oluşturulan Kemik Defektleri Üzerine Etkilerinin Araştırılması

Project Supported by Higher Education Institutions , BAP Research Project

(Project Abstract) (Project Final Report)

YALTIRIK M. (Executive), AHISHALI B., TURGUT C. T., ÖZTÜRK D., OKYAR A., GÜNGÖR S., et al.

2017 - 2020

Topikal Vesiküler ilaç taşıyıcı sistemlerin optimizasyonu

Project Supported by Higher Education Institutions , BAP Other

GÜNGÖR S. (Executive), ERDAL M. S.

2017 - 2020

Topical Nanosized Colloidal Carriers of Tacrolimus Development Characterization and Skin Uptake Studies

Project Supported by Higher Education Institutions , BAP Other

GÜNGÖR S. (Executive), ERDAL M. S., GÜNGÖRDÜK S.

2016 - 2019

Dendritik Nanotaşıyıcı Sistemlerin Dermal Hedeflendirme Açısından Değerlendirilmesi

Project Supported by Higher Education Institutions , BAP PhD

GÜNGÖR S. (Executive), GÖKÇE B. B.

2017 - 2018

Skin Penetration Enhancement Mechanism of Mixed Micelles

Project Supported by Higher Education Institutions , BAP Other

KAHRAMAN ŞİRİN E. (Executive), ERGİNER Y., GÜNGÖR S.

2017 - 2018

Mikroemülsiyon tipi kolloidal taşıyıcı sistemlerin antifungal aktivitelerinin tayin edilmesi

Project Supported by Higher Education Institutions , BAP Other

ERDAL M. S. (Executive), ERGİNER Y., GÜNGÖR S., MAT C.

2017 - 2018

Sertaconazole loaded nanofibers as topical drug carriers

Project Supported by Higher Education Institutions , BAP Other

ERDAL M. S. (Executive), GÜNGÖR S., ESENTÜRK İ.

2017 - 2018

Penetration EnhancerContaining Nanomicelles for Topical Delivery Impact on Skin Barrier

Project Supported by Higher Education Institutions , BAP Other

ERGİNER Y. (Executive), KAHRAMAN E., GÜNGÖR S.

2017 - 2018

Topikal Preparatların İn vitro Deriden Geçişlerinin Değerlendirilmesinde Kullanılan Membranların Karşılaştırılması

Project Supported by Higher Education Institutions , BAP MSc

GÜNGÖR S. (Executive), KOCABAŞ N. Ö.

2017 - 2018

DİYABET TEDAVİSİ İÇİN SABİT DOZ KOMBİNASYONLU TABLET FORMÜLASYONUNUN GELİŞTİRİLMESİ

Project Supported by Higher Education Institutions , BAP Other

ERGİNER Y. (Executive), GÜNGÖR S.

2017 - 2018

In vitro Hücre Kültürü Modeli Kullanarak İlaç Yüklü Nano Taşıyıcıların Biyolojik Aktivitelerinin Değerlendirilmesi

Project Supported by Higher Education Institutions , BAP Other

GÜNGÖR S. (Executive), REZIGUE M.

2016 - 2017

Atopik Dermatit Tedavisine Yönelik Topikal Nano İlaç Taşıyıcı Sistemlerin Optimizasyonu İn vitro/İn vivo Değerlendirilmesi

Project Supported by Higher Education Institutions , BAP PhD

GÜNGÖR S. (Executive), GÜNGÖRDÜK S.

2016 - 2017

Topikal Psoriazis Tedavisi için Nano Boyutlu İlaç Taşıyıcı Sistemlerin Geliştirilmesi ve İn vitro Modeller ile Değerlendirilmesi

Project Supported by Higher Education Institutions , BAP PhD

GÜNGÖR S. (Executive), REZİGUE M.

2016 - 2017

Flurbiprofen yüklü koloidal taşıyıcı sistemlerin formülasyon optimizasyonunun yapay sinir ağları kullanılarak gerçekleştirilmesi ve ilacın deriye penetrasyonunun in vitro koşullarda incelenmesi

Project Supported by Higher Education Institutions , BAP Other

ERDAL M. S. (Executive), ÖZHAN G., GÜNGÖR S., GÜRBÜZ A., GÜNGÖRDÜK S.

2014 - 2016

OKÜLER UYGULAMAYA YÖNELİK TAKROLİMUS YÜKLÜ PLURONİK MİSELLERİN HAZIRLANMASI

Project Supported by Higher Education Institutions , BAP Research Project

ERGİNER Y. (Executive), GÜNGÖR S., KAHRAMAN E.

2013 - 2016

Atopik Dermatit Tedavisine Yönelik Yenilikçi Topikal Formülasyonların Geliştirilmesi

Industrial Thesis Project

Güngör S. (Executive), Erdal M. S.

2013 - 2016

TOPİKAL VEZİKÜLER İLAÇ TAŞIYICI SİSTEMLERİN OPTİMİZASYONU VE FARKLI LİPOFİLİTEYE SAHİP MODEL İLAÇLAR İLE YÜKLENEREK DERMAL HEDEFLENDİRİLMELERİNİN ARAŞTIRILMASI

Project Supported by Higher Education Institutions , BAP Other

ERDAL M. S. (Executive), GÜNGÖR S.

2015 - 2015

Polimerik Misel İlaç Taşıyıcı Sistemlerin Deriden Geçiş Mekanizmalarının ve Derideki Lokalizasyonlarının Görüntüleme Teknikleri ile In vitro İncelenmesi

Project Supported by Higher Education Institutions , BAP Other

GÜNGÖR S. (Executive)

2013 - 2014

TOPİKAL UYGULAMAYA YÖNELİK MİSELLERİN GELİŞTİRİLMESİ VE OPTİMİZASYONU

Project Supported by Higher Education Institutions , BAP Other

GÜNGÖR S. (Executive)

2011 - 2014

Kan dolaşımında uzun süre kalabilen polimerik yapıdaki nanopartiküllerin geliştirilmesi, karakterizasyonu ve hedeflendirilmesi

TUBITAK Project

GÜNGÖR S., PABUCCUOĞLU S. K., GÖK M. K.

2012 - 2013

Etodolak'ın Topikal Mikroemülsiyon Formülasyonlarının Geliştirilmesi ve In vitro Karakterizasyonu Çalışmaları

Project Supported by Higher Education Institutions , BAP MSc

GÜNGÖR S. (Executive)

2011 - 2013

Transdermal iyontoforetik geçiş üzerinde lipofilite etkisinin incelenmesi

Project Supported by Higher Education Institutions , BAP Other

GÜNGÖR S. (Executive)

2010 - 2013

Peptit yapısındaki ilaçların trans-skleral iyontoforetik geçişinin incelenmesi

Project Supported by Higher Education Institutions , BAP Other

GÜNGÖR S. (Executive)

2010 - 2012

Antiemetik ilaçların transdermal iyontoforetik geçişinin incelenmesi

Project Supported by Higher Education Institutions , BAP MSc

GÜNGÖR S. (Executive)

2011 - 2011

Ondansetron Hidroklorür'ün İn vitro İyontoforetik Taşınması: Elektromigrasyon ve Elektroozmosun Katkısı

Project Supported by Higher Education Institutions , BAP Other

GÜNGÖR S. (Executive)

2009 - 2011

Transcutol®? un yardımcı çözücü olarak terpenler ile birlikte, derinin bariyer işlevi üzerindeki etkisinin, farklı lipofiliteye sahip model etkin maddeler kullanılarak incelenmesi

Project Supported by Higher Education Institutions , BAP Other

GÜNGÖR S. (Executive)

2009 - 2009

Vankomisin?in in vitro trans-skleral iyontoforetik transportu

Project Supported by Higher Education Institutions , BAP Other

GÜNGÖR S. (Executive)

Patent

2019

TOPİKAL FORMÜLASYONLAR

Patent

Registered / Approved, The Invention Registration Number: 2015 13223 , Standard Registration

Memberships and Roles in Scientific Organizations

2020 - Present

Controlled Release Society

Member

2011 - Present

Kontrollü salım Sistemleri Derneği

Secretary General

1992 - Present

Türk Farmasötik Teknoloji Araştırmacıları Derneği

Member

Peer Reviews in Scientific Publications

September 2016

Aritifical Cells, Nanomedicine and Biotechnology

SCI Journal

June 2016

Skin Pharmacology and Physiology

SCI Journal

June 2016

Biomedical Chromatography

SCI Journal

May 2016

International Journal of Pharmaceutics

SCI Journal

April 2016

International Journal of Pharmaceutics

SCI Journal

December 2015

Journal of Pharmacy and Pharmacology

SCI Journal

October 2015

Journal of Pharmacy and Pharmacology

SCI Journal

September 2015

Artificial Cells, Nanomedicine and Biotechnology

SCI Journal

June 2015

International Journal of Pharmaceutics

SCI Journal

March 2015

Current Drug Targets

SCI Journal

February 2015

Journal of Pharmacy & Pharmacology

SCI Journal

January 2015

European Journal of Pharmaceutics & Biopharmaceutics

SCI Journal

January 2015

European Journal of Pharmaceutics & Biopharmaceutics

SCI Journal

July 2014

European Journal of Pharmaceutics & Biopharmaceutics

SCI Journal

February 2014

European Journal of Pharmaceutics & Biopharmaceutics

SCI Journal

Scientific Project Refereeing

September 2020

TUBITAK Project

1001 - Program for Supporting Scientific and Technological Research Projects, TÜBİTAK, Turkey

August 2020

TUBITAK Project

1512 - Progressive Support Program for Entrepreneurship, TÜBİTAK-TEYDEB, Turkey

Roles in Event Organizations

May 2010

KSSD Girit Toplantısı-Farmasötik Denetimler için PIC/S Üyeliği.

Workshop Organization

Erginer Y., Güngör S.

Greece

May 2009

Kontrollü Salım Sistemleri 6. Sempozyumu

Scientific Congress

Erginer Y., Güngör S.

İstanbul, Turkey

October 2007

Kontrollü Salım Sistemleri 5. Sempozyumu

Scientific Congress

Erginer Y., Güngör S.

İstanbul, Turkey

September 2007

The 5th International Postgraduate Research Symposium on Pharmaceutics with the Participation of Undergraduates (IPORSIP-2007)

Scientific Congress

Erginer Y., Güngör S.

Turkey

May 2005

Kontrollü Salım Sistemleri 4. Sempozyumu

Scientific Congress

Erginer Y., Güngör S.

İstanbul, Turkey

September 2004

The 4th International Postgraduate Research Symposium on Pharmaceutics with the Participation of Undergraduates (IPORSIP-2004)

Scientific Congress

Erginer Y., Güngör S.

İstanbul, Turkey

May 2003

Kontrollü Salım Sistemleri 3.Sempozyumu

Scientific Congress

Erginer Y., Güngör S.

İstanbul, Turkey

September 2002

The Third International Postgraduate Research Symposium on Pharmaceutics with the Participation of Undergraduates (IPORSIP-2002)

Scientific Congress

Erginer Y., Güngör S.

İstanbul, Turkey

May 2001

Kontrollü Salım Sistemleri 2.Sempozyumu

Scientific Congress

Erginer Y., Güngör S.

İstanbul, Turkey

September 2000

The Second International Postgraduate Research Symposium on Pharmaceutics with the Participation of Undergraduates (IPORSIP-2000)

Scientific Congress

Erginer Y., Güngör S.

İstanbul, Turkey

September 1999

Kontrollü Salım Sistemleri 1.Sempozyumu

Scientific Congress

Erginer Y., Güngör S.

İstanbul, Turkey

July 1998

The First International Postgraduate Research Symposium on Pharmaceutics (IPORSIP’98)

Scientific Congress

Erginer Y., Güngör S.

İstanbul, Turkey

Awards

December 2011

Kimyevi Maddeler ve Mamülleri Sektörü1. Ar-Ge Pazarİlaç ve Eczacılık Ürünleri Dalında Proje Birincilik Ödülü.

İstanbul Kimyevi Maddeler ve Mamulleri İhracatçıları Birliği (İKMİB)

December 2011

Kimyevi Maddeler ve Mamülleri Sektörü1. Ar-Ge Pazarİlaç ve Eczacılık Ürünleri Dalında Proje İkincilik Ödülü.

İstanbul Kimyevi Maddeler ve Mamulleri İhracatçıları Birliği (İKMİB)

May 2010

Farmasötik Teknoloji Araştırma Destek Ödülü

Novartis İlaçları Türkiye

April 2004

Farmasötik Teknoloji Araştırma Destek Ödülü

Novartis İlaçları Türkiye

Congress and Symposium Activities

06 March 2021 - 06 March 2021

Covid-19 Aşıları: Formülasyon, Kalite, Etkinlik, Güvenlilik ve Yerli Üretimi

Audience

Ankara-Turkey

05 March 2021 - 05 March 2021

Controlled Release Society (CRS) LOcal Chapers- Arjganitne Webinar

Audience

Rio Negro-Argentina

17 February 2021 - 17 February 2021

Netzsch "From R&D to Production, DeltaVita‘s for Nanonization of API".

Audience

Munich-Germany

05 February 2021 - 05 February 2021

Controlled Release Society (CRS) Local Chapers- Nordic Webinar

Audience

Kobenhavn-Denmark

06 January 2021 - 06 January 2021

Controlled Release Society (CRS) LOcal Chapers- Taiwan Webinar

Audience

Hsin-Chu-Taiwan

20 October 2020 - 21 October 2020

TÜBİTAK 2237B İhtisaslaşan Üniversitelere Yönelik Çevirimiçi Proje Yazma Eğitimi – SAĞLIK GRUBU, 21 Ekim 2020

Invited Speaker

İstanbul-Turkey

20 October 2020 - 21 October 2020

TÜBİTAK 2237B İhtisaslaşan Üniversitelere Yönelik Çevirimiçi Proje Yazma Eğitimi – SAĞLIK GRUBU, 21 Ekim 2020

Invited Speaker

İstanbul-Turkey

20 October 2020 - 21 October 2020

TÜBİTAK 2237B İhtisaslaşan Üniversitelere Yönelik ÇevirimiçiProje Yazma Eğitimi –SAĞLIK GRUBU,

Invited Speaker

İstanbul-Turkey

21 February 2020 - 23 February 2020

10. Uluslararası Kozmetik Kimyası, Üretimi ve Standardizasyonu Kongresi

Invited Speaker

Antalya-Turkey

22 January 2020 - 24 January 2020

XIII Spanish-Portuguese Conference on Controlled Drug Delivery

Invited Speaker

A-Coruna-Spain

01 June 2016 - 01 June 2016

100. Skin Forum Annual Meeting

Attendee

London-United Kingdom

01 April 2016 - 01 April 2016

102. World Congress & Expo on Pharmaceutics & Drug Delivery Systems (Pharmaceutics-2016),

Attendee

Dubayy-United Arab Emirates

01 March 2016 - 01 March 2016

2nd Annual World Congress of Smart Materials-2016 (WCSM-2016),

Attendee

Singapore-Singapore

01 October 2015 - 01 October 2015

99. 2015 AAPS Annual Meeting and Exposition

Attendee

Florida-United States Of America

01 July 2015 - 01 July 2015

2015 CRS Annual Meeting & Exposition

Attendee

Edinburgh-United Kingdom

01 July 2015 - 01 July 2015

Controlled Release Society Annual Meeting 2015

Attendee

Edinburgh-United Kingdom

01 May 2015 - 01 May 2015

BASF’nin düzenlediği İlaç Teknolojileri Konferansı, Pharmaceutical Technologies: Skin Delivery & Solid Dosage Forms

Attendee

İstanbul-Turkey

01 April 2015 - 01 April 2015

GE Healthcare, New Technologies and Regulatory Updates in Development and Mnufacturing of Biologicals

Attendee

İstanbul-Turkey

01 April 2015 - 01 April 2015

From the Chain Bridge to other Bridges of the Pharmaceutical World

Attendee

Antalya-Turkey

01 April 2015 - 01 April 2015

İyi Klinik Uygulamalar ve Temel Klinik Araştırma Eğitimi, İstanbul, Nisan 2015

Attendee

İstanbul-Turkey

01 April 2015 - 01 April 2015

1st European Conference on Pharmaceutics: Drug Delivery

Attendee

Reims-France

01 March 2015 - 01 March 2015

The Global Bioequivalence Harmonisation Initiative

Attendee

Amsterdam-Netherlands

01 December 2014 - 01 December 2014

4th International Conference on Nanotek & Expo

Attendee

San Francisco-United States Of America

01 November 2014 - 01 November 2014

ISPE Sağlık Bilimleri Derneği Eğitim Semineri: Ürün Tasarımında ve Üretim Kontrollerinde Yeni Yaklaşımlar,

Attendee

Point Hotel, İstanbul-Turkey

01 October 2014 - 01 October 2014

İlaçta Ar-Ge; Kamu, Üniversite, Sanayi İşbirliğinin Önemi, İstanbul Wyndham Levent Hotel

Attendee

İstanbul-Turkey

01 October 2014 - 01 October 2014

İlaçta Ar-Ge; Kamu, Üniversite, Sanayi İşbirliğinin Önemi

Attendee

Wyndham Levent Hotel,İstanbul -Turkey

01 September 2014 - 01 September 2014

Symposium on Biosimilars, Fourth International Meeting onPharmacy&Pharmaceutical Sciences

Attendee

İstanbul-Turkey

01 September 2014 - 01 September 2014

Skin Forum 14th Annual Meeting

Attendee

Prague-Czech Republic

01 May 2014 - 01 May 2014

ISPE Sağlık Bilimleri Derneği Pulmoner İlaç Salım Sistemleri Çalıştayı

Attendee

İstanbul-Turkey

01 May 2014 - 01 May 2014

ISPE Sağlık Bilimleri Derneği Eğitim Semineri: Pulmoner İlaç Salım Sistemleri Çalıştayı

Attendee

İstanbul Üniversitesi Eczacılık Fakültesi, İstanbul-Turkey

01 May 2014 - 01 May 2014

ISPE Sağlık Bilimleri Derneği Biyolojik Ürünler ve Biyobenzerler: Bütünsel Yaklaşım

Attendee

İstanbul-Turkey

01 March 2014 - 01 March 2014

9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

Attendee

LISBON-Portugal

01 December 2013 - 01 December 2013

3rd International Conference on Nanotek & Expo, NANOTEK-2013

Attendee

LAS VEGAS-United States Of America

01 November 2013 - 01 November 2013

İlaç Temel Araştırma Merkezi (İTAM) Projesi İlaçAraştırmaları ve Farmasötik Kimya

Attendee

İstanbul-Turkey

01 November 2013 - 01 November 2013

Türkiye İlaç ve Tıbbi Cihaz Kurumu & ISPE Sağlık Bilimleri Derneği GDP Kılavuzu ve Getireceği Yenilikler" Semineri

Attendee

İstanbul-Turkey

01 October 2013 - 01 October 2013

ISBS/SICC 1st Joint International Congress

Attendee

MILAN-Italy

01 June 2013 - 01 June 2013

Annual Skin Forum Meeting

Attendee

London-Turkey

01 May 2013 - 01 May 2013

ISPE - Sağlık Bilimleri Derneği Eğitim Semineri“QbD ve PAT Kapsamında Hammadde Değiskenliği ile Depolama ve Dağıtım Uygulamaları

Attendee

İSTANBUL-Turkey

01 January 2013 - 01 January 2013

Ekin Kimya, USP 6th Science & Standards Symposium

Attendee

İstanbul-Turkey

01 November 2012 - 01 November 2012

Parkoteks Kimya San. ve Tic. Ltd. Şti., Lubrizol, Farmasötik Polimerler

Attendee

İstanbul-Turkey

01 November 2012 - 01 November 2012

ISPE Sağlık Bilimleri Derneği Eğitim Semineri: Containment Semineri,

Attendee

İstanbul-Turkey

01 November 2012 - 01 November 2012

World Congress of the International Society for Biophysics & Imaging of the Skin (ISBS), ,, Danimarka.

Attendee

Kopenhag-Denmark

01 September 2012 - 01 September 2012

16th International Pharmaceutical Technology Symposium, in Türkiye

Attendee

Antalya-Turkey

01 July 2012 - 01 July 2012

The 39th Annual Meeting of Controlled Release Society, .

Attendee

Quebec City-Canada

01 June 2012 - 01 June 2012

3rd International Regulatory Workshop on A to Z on Bioequivalence Bioanalysis, Dissolution and Biosimilarity (BEW)

Attendee

Budapeşte-Hungary

01 June 2012 - 01 June 2012

18th EGA Annual Conference "Healthy and Active Ageing Through Improved Access to Affordable Generic Medicines

Attendee

St Julian's-Malta

01 April 2012 - 01 April 2012

ISPE Sağlık Bilimleri Derneği Semineri

Attendee

İstanbul -Turkey

01 March 2012 - 01 March 2012

DIA 24th Annual EuroMeeting,

Attendee

Bella Center, Kopenhag-Denmark

01 March 2012 - 01 March 2012

8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

Attendee

Istanbul, -Turkey

Scholarships

2007 - 2008

Ziyaretçi Araştırıcı Bursu

University

2006 - 2006

Ziyaretçi Araştırıcı Bursu

University

2005 - 2006

2219-Yurt Dışı Doktora Sonrası Araştırma Burs Programı Bursu

TUBITAK

Citations

Total Citations (WOS): 705

h-index (WOS): 17

Jury Memberships

March-2021

March 2021

Doctoral Examination

BİLGE SÜRÜCÜ DOKTORA YETERLİK SINAVI - İstanbul Üniversitesi

February-2021

February 2021

Doctoral Examination

Arkan Yashar Barbar Doktora Yeterlik Sınavı - Altınbaş Üniversitesi

January-2021

January 2021

Doctoral Examination

M. Mayowa ONAYO Doktora Yeterlik Sınavı - Yakın Doğu Üniversitesi

January-2021

January 2021

Doctoral Examination

Joseph T. CHUNU Doktora Yeterlik Sınavı - Yakın Doğu Üniversitesi

December-2020

December 2020

Doctoral Examination

Ali Akkaya Doktora Yeterlik Sınavı - İstanbul Üniversitesi

December-2020

December 2020

Doctorate

Nailla JIWA "Use of compaction simulator to observe the effect of co-processed lactose based fillers and lubricants on directly compressible Ibuprufen by Quality by Design" Başlıklı Tezi - Yakın Doğu Üniversitesi

October-2020

October 2020

Doctoral Examination

Cemre İrem Aygüler Doktora Yeterlilik Sınavı - İstanbul Üniversitesi

September-2020

September 2020

Doctoral Examination

Ecz. Nurbanu Demirtürk Doktora Yeterlik Sınavı Jüri Üyeliği - Hacettepe Üniversitesi

September-2020

September 2020

Associate Professor Exam

AHMET ALPER ÖZTÜRK Doçentlik Jüri Üyeliği - Istanbul University

August-2020

August 2020

Expertise In Medicine

ALAA ALGHANANIM, PhD THESIS TITLED by Development and Characterization Studies on a Solid Self Nano Emulsifying Drug Delivery System of Deferasirox - Yakın Doğu Üniversitesi

August-2020

August 2020

Post Graduate

ABDULKADER RAWAS MASTER THESIS TITLED by DEVELOPMENT AND OPTIMIZATION OF THE TOPICAL APPLICATION OF ESSENTIAL OIL-BASED NANOEMULSION (EO-NE) FOR WOUND HEALING, - Yakın Doğu Üniversitesi

August-2020

August 2020

Post Graduate

ASMA SHAHBAZ MASTER THESIS TITLED by DEVELOPMENT AND OPTIMIZATION OF ESSENTIAL OIL BASED NANOEMULSION (NE) SYSTEM FOR TOPICAL TREATMENT OF CANDIDIASIS - Yakın Doğu Üniversitesi

August-2020

August 2020

Doctoral Examination

YAĞMUR PİRİNÇÇİ TOK DOKTORA YETERLİK SINAVI - İstanbul Üniversitesi

June-2020

June 2020

Doctoral Examination

Çağlan Çavuşoğlu Doktora Yeterlik Sınavı - İstanbul Üniversitesi

June-2020

June 2020

Doctoral Examination

Hümeyra Şahin Bektay Doktora Yeterlik Sınavı - İstanbul Üniversitesi

June-2020

June 2020

Doctoral Examination

Buşra Pelen Doktora Yeterlik Sınavı - İstanbul Üniversitesi

June-2020

June 2020

Doctoral Examination

Elmira Kalami Doktora Yeterlik Sınavı - İstanbul Üniversitesi

June-2016

June 2016

Doctoral Examination

- İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü

June-2016

June 2016

Doctoral Examination

- İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü

June-2016

June 2016

Doctoral Examination

- İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü

February-2016

February 2016

Assistant Professorship Appointment Committee

- Kemerburgaz Üniveristesi Eczacılık Fakültesi

June-2015

June 2015

Doctoral Examination

- İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü

June-2015

June 2015

Doctorate

- İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü

May-2015

May 2015

Doctoral Examination

- İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü

March-2015

March 2015

Award

TÜBA Bilimsel Telif ve Çeviri Eser Ödülleri Programı - Türkiye Bilimler Akademisi (TÜBA)

October-2014

October 2014

Doctoral Examination

- İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü

July-2014

July 2014

Doctoral Examination

- İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü

July-2014

July 2014

Post Graduate

- İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü

May-2014

May 2014

Doctorate

- istanbul Üniversitesi Sağlık Bilimleri Enstitüsü

March-2014

March 2014

Doctoral Examination

- Sağlık Bilimleri Enstitüsü

March-2014

March 2014

Doctoral Examination

- Sağlık Bilimleri Enstitüsü

March-2014

March 2014

Doctoral Examination

- Sağlık Bilimleri Enstitüsü

March-2014

March 2014

Doctoral Examination

- İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü

January-2014

January 2014

Post Graduate

- Marmara Üniversitesi Sağlık Bilimleri Enstitüsü

July-2013

July 2013

Doctoral Examination

- İSTANBUL ÜNİVERSİTESİ SAĞLIK BİLİMLERİ ENSTİTÜSÜ

July-2013

July 2013

Doctoral Examination

- İSTANBUL ÜNİVERSİTESİ SAĞLIK BİLİMLERİ ENSTİTÜSÜ

July-2013

July 2013

Post Graduate

- MARMARA ÜNİVERSİTESİ SAĞLIK BİLİMLERİ ENSTİTÜSÜ

February-2013

February 2013

Doctoral Examination

- İSTANBUL ÜNİVERSİTESİ SAĞLIK BİLİMLERİ ENSTİTÜSÜ

February-2013

February 2013

Doctoral Examination

- İSTANBUL ÜNİVERSİTESİ SAĞLIK BİLİMLERİ ENSTİTÜSÜ

February-2013

February 2013

Doctoral Examination

- İSTANBUL ÜNİVERSİTESİ SAĞLIK BİLİMLERİ ENSTİTÜSÜ

February-2013

February 2013

Doctoral Examination

- İSTANBUL ÜNİVERSİTESİ SAĞLIK BİLİMLERİ ENSTİTÜSÜ

February-2013

February 2013

Doctoral Examination

- İSTANBUL ÜNİVERSİTESİ SAĞLIK BİLİMLERİ ENSTİTÜSÜ

June-2012

June 2012

Doctoral Examination

- İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü

June-2012

June 2012

Doctoral Examination

- İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü

February-2012

February 2012

Doctoral Examination

- İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü

Scientific Research / Working Group Memberships

2020 - Present